2019 Handouts
ALL HANDOUTS
SESSION 1: AWARD CONTENDERS I
1.1 Beyond the Autopsy: Postmortem Familial Variant Testing
***Kathryn Pinneri, MD, Montgomery County Forensic Services, Conroe, Texas, United States of America
1.2 An Assessment of Cardiomegaly and Opioid-Related Death
****Richard Seeber, II, BS, BA, UAB School of Medicine, Birmingham, Alabama, United States of America
1.3 Placental Refractile Material Identified in Three Cases of Intrauterine Demise Due to Known, Reported, and Suspected Misoprostol Use
*Daniel C Butler, MD, Medical University of South Carolina, Charleston, South Carolina, United States of America
1.4 Forensic Aspects, Challenges and Legal Cconsequences of the Munchhausen by Proxy Syndrome
*Iana Lesnikova, MD, PhD, Department of Pathology Rush University Medical Center, Chicago, Illinois, United States of America
SESSION 2: AWARD CONTENDERS II
2.2 Fatal Brodifacoum Poisoning with Synthetic Marijuana
***Jarred Michalski, MD, University of South Florida Morsani College of Medicine, Tampa, Florida, United States of America
2.3 A Poison Most Peculiar: Suicide by Sodium Azide
*Julia Denise Berry, MD, Baylor University Medical Center, Dallas, Texas, United States of America
2.4 Beta-Hydroxybutyric acid (BHB) Testing in Postmortem Blood to Differentiate Between Solvent Ingestion and DKA
**Laura M. Labay, PhD, NMS Labs, Horsham, Pennsylvania, United States of America
2.5 Use of BioFire® FilmArray® in a Medical Examiner's Office: A Case Series
Megan Lee, MD, University of Missouri, Columbia, Missouri, United States of America
SESSION 3: AWARD CONTENDERS III
3.1 A New Way to Look at Data: Collaboration Between the Cook County Medical Examiner's Office and the Bureau of Technology
***Michael D Eckhardt, MD, Cook County Medical Examiner's Office, Chicago, Illinois, United States of America
3.3 Improving Infectious Disease Reporting in a Medical Examiner’s Office
***Christopher Rogers, MD, MBA, Los Angeles County, Los Angeles, California, United States of America and Lakshmanan Sathyavagiswaran, MD, FRCPC, FACP, FCAP, Los Angeles County, Los Angeles, California, United States of America
3.4 Critical Diagnoses and Duty to Warn in Forensic Pathology: An Evaluation of Ethics and Proposed Reporting Recommendations
*Cori Ann Breslauer, MD, North Carolina Office of the Chief Medical Examiner, Raleigh, North Carolina, United States of America
3.5 Attitudes Towards Forensic Autopsy Standard B3.7 and the Use of Physician Extenders in Select Autopsy Cases
*Cassie B. MacRae, M.Sc., M.D., Beth Israel Deaconess Medical Center/Harvard Medical School, Boston, Massachusetts, United States of America
3.7 Utilization of Pathologists’ Assistants within the Medical Examiner Setting: Bridging the Gap Between Forensic Pathologist Shortage and Increasing Workloads
***Milad Webb, MD, PhD, University of Michigan/Wayne County Medical Examiner's Office, Detroit, Michigan, United States of America and Carl J. Schmidt, MD, University of Michigan / Wayne County Medical Examiner's Office, Detroit, Michigan, United States of America
SESSION 4: MISCELLANEOUS
4.1 The Great Smoky Mountain Wildfires
Katherine Cochrane, MD, University of Tennessee Medical Center Knoxville, Knoxville, Tennessee, United States of America
4.4 Faith or Delusion: Death Investigation of a Bizarre Mass Hanging- A Case Report and Review of Literature
Monisha Pradhan, MD, Maulana Azad Medical College, New Delhi, Delhi, India
4.5 The Perforated Jejunum: A Case Series
Hannah Claire Jarvis, MBBS BSc(Hons) MRCS(Eng), Harris County Institute of Forensic Sciences, Houston, Texas, United States of America and Rafael A Garcia, MD, Harris County Institute of Forensic Sciences, Houston, Texas, United States of America
4.6 They Say, “Don’t Mess With Texas”: A Review of Police-Involved Fatalities from Regions of Texas
Jessica B Dwyer, MD, Southwestern Institute of Forensic Sciences, Dallas, Texas, United States of America
4.7 Multi-Institutional Multi-Disciplinary Injury Mortality Investigation in the Civilian Pre-Hospital Environment (MIMIC): Concept of Utilizing Medical Examiner Data to Determine Prehospital Injury Survivability
C Lizette Villarreal, MA, National Trauma Institute, San Antonio, Texas, United States of America and Brian J Eastridge, MD, University of Texas Health Science Center at San Antonio, San Antonio, Texas, United States of America
4.9 Around the World in One Hundred and Eighty Days: How Much Has Twitter "Disrupted" Hierarchies in Forensic Pathology?
Ken Obenson, MD, Saint John Regional Hospital, Saint John, New Brunswick, Canada
SESSION 5: WORKSHOP
5.1 Unexplained Pediatric Deaths: Investigation, Certification and Family Needs
Elizabeth A Bundock, MD, PhD, Office of the Chief Medical Examiner, Burlington, Vermont, United States of America, Kathryn Pinneri, MD, Montgomery County Forensic Services, Conroe, Texas, United States of America, Laura D. Knight, MD, Washoe County Regional Medical Examiner’s Office, Reno, Nevada, United States of America, Laura Gould Crandall, MA, NYU School of Medicine, New York, New York, United States of America, Richard D. Goldstein, MD, Boston Children's Hospital, Boston, Massachusetts, United States of America and Mary Ann Sens, MD, PhD, University of North Dakota School of Medicine and Health Sciences, Grand Forks, North Dakota, United States of America
SESSION 6: WORKSHOP
6.1 Pharmacokinetics, Genetic Polymorphisms, and Drug-Drug Interactions
Laura M. Labay, PhD, NMS Labs, Willow Grove, Pennsylvania, United States of America, Jirair Gevorkyan, PhD, Office of the Chief Medical Examiner City and County of San Francisco, San Francisco, California, United States of America and Luigino Apollonio, PhD, Cuyahoga County Medical Examiner's Office, Cleveland, Ohio, United States of America
SESSION 7: TOXICOLOGY
7.1 The Issue of the Interpretation of Morphine in Postmortem Toxicology
Karl E Williams, MD, MPH, Office of the Medical Examiner of Allegheny County, Pittsburgh, Pennsylvania, United States of America
7.2 Identification and Quantification of Exogenous Insulin Analogs in Postmortem Specimens
Laura M. Labay, PhD, NMS Labs, Horsham, Pennsylvania, United States of America
7.3 Involvement of Synthetic Cannabinoids as Cause or Contributing Cause of Death
Barry K Logan, PhD, NMS Labs, Horsham, Pennsylvania, United States of America
7.4 Looking Ahead to Toxicology in 2020: A Presentation from the NAME Toxicology Committee
Laura M. Labay, PhD, NMS Labs, Horsham, Pennsylvania, United States of America
SESSION 8: PEDIATRIC FORENSIC PATHOLOGY AND CARDIAC PATHOLOGY
8.2 Gross and Histologic Comparison of Acute and Chronic Skull Fractures to Typical and Accessory Sutures of the Infant Skull
Agnieszka Rogalska, MD, Dane County Medical Examiner's Office, McFarland, Wisconsin, United States of America
8.3 Tackling the Challenges of Fetal Autopsies in the Setting of Maternal Trauma
Benjamin Daggett, MD, University of Alabama Hospitals, Birmingham, Alabama, United States of America and Daniel S Atherton, MD, Jefferson County Coroner/Medical Examiner’s Office, Birmingham, Alabama, United States of America
8.5 Mechanisms of Cerebral Edema in Abusive Head Trauma
Rudolph J Castellani, Jr, MD, West Virginia University, Morgantown, West Virginia, United States of America
8.7 The Autopsy Pathologist and Extracorporeal Membrane Oxygenation (ECMO)
Abraham T. Philip, M.B.B.S., MD, Cobb County Medical Examiner's Office, Marietta, Georgia, United States of America
SESSION 9: MOLECULAR DIAGNOSTICS
9.1 The "Molecular Autopsy": Real Life Experience in a Medical Examiner's Office
Michael D. Bell, M.D., Palm Beach County Medical Examiner Office, West Palm Beach, Florida, United States of America
9.2 Use of Molecular Autopsy in Cases of Suspected Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)
Kristen De Berg, MS, Sanford Health, Sioux Falls, South Dakota, United States of America and Kenneth Snell, MD, Sanford Health, Sioux Falls, South Dakota, United States of America
SESSION 10: ADMINISTRATIVE
10.1 ISO17020:2012 Accreditation and NAME Accreditation: Our Experience and Removing the Misconceptions
Amy C. Gruszecki, MSFS, DO, American Forensics, Mesquite, Texas, United States of America, Sally Aiken, MD, Spokane County Medical Examiner's office, Spokane, Washington, United States of America, Barbara C. Wolf, MD, Districts 5 & 24 Medical Examiner's Office, Leesburg, Florida, United States of America, Ponni Arunkumar, MD, Cook County Medical Examiner's Office, Chicago, Illinois, United States of America, and Roger Mitchell, MD, Office of the Chief Medical Examiner, Washington, District of Columbia, United States of America
10.2 2019 Salary Survey Results
William Oliver, MD, Regional Forensic Center, Knoxville, Tennessee, United States of America
10.3 Check Please: The Importance of The Pregnancy Check Box On Death Certificates in Identifying Pregnancy-Related Deaths
Jan M. Gorniak, DO, MHSA, Fulton County Medical Examiner's Office, Atlanta, Georgia, United States of America
10.4 Reclaiming the Autopsy as the Practice of Medicine: A Pathway to Remediation of the Forensic Pathology Workforce Shortages?
Victor W. Weedn, MD, JD, George Washington University, Washington, District of Columbia, United States of America and MJ Menendez, JD, Philadelphia, Pennsylvania, United States of America
SESSION 12: ALPHABET SOUP
12.4 ECHO: Medicolegal Death Investigation - A Novel Solution to Training and Certifying Forensic Medicolegal Death Investigators in a Geographically Distributed Medical Examiner System
Ian Daniel Paul, MD, Office of the Medical Investigator, University of New Mexico, Albuquerque, New Mexico, United States of America
12.5 Automated Drug-Involved Death Data Collection Pilot
Steven Clark, PhD, Occupational Research and Assessment, Big Rapids, Michigan, United States of America
12.6 Preventing Consumer Product-Related Deaths: The Vital Role of Medical Examiners
Yolanda Nash, BS, U.S. Consumer Product Safety Commission, Bethesda, Maryland, United States of America
|
